Imatinib is used clinically for the treatment of several diseases including chronic myeloid leukemia (CML) and KIT—positive gastrointestinal stromal tumors (GISTs) [10]. The gene discussed is KIT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.